Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Organ Transplantation | 48 | 2023 | 1140 | 10.020 |
Why?
|
Kidney Transplantation | 134 | 2021 | 4251 | 7.860 |
Why?
|
Graft Rejection | 120 | 2023 | 4397 | 6.700 |
Why?
|
Graft Survival | 87 | 2022 | 3737 | 6.350 |
Why?
|
Tissue Donors | 61 | 2023 | 2241 | 5.960 |
Why?
|
Transplantation Immunology | 20 | 2018 | 546 | 3.920 |
Why?
|
Facial Transplantation | 17 | 2021 | 226 | 3.400 |
Why?
|
Reperfusion Injury | 25 | 2022 | 1026 | 3.400 |
Why?
|
Immunosuppressive Agents | 60 | 2020 | 4153 | 2.810 |
Why?
|
Brain Death | 19 | 2023 | 348 | 2.470 |
Why?
|
Aging | 28 | 2023 | 8663 | 2.430 |
Why?
|
Organ Preservation | 15 | 2023 | 331 | 2.210 |
Why?
|
Transplantation | 9 | 2020 | 217 | 2.130 |
Why?
|
Transplantation, Homologous | 75 | 2023 | 4777 | 2.100 |
Why?
|
Uterus | 8 | 2022 | 711 | 1.980 |
Why?
|
Rats, Inbred Lew | 71 | 2023 | 1162 | 1.940 |
Why?
|
Tissue and Organ Procurement | 15 | 2023 | 896 | 1.940 |
Why?
|
Immunity, Innate | 10 | 2020 | 2962 | 1.890 |
Why?
|
Rats, Inbred F344 | 58 | 2012 | 862 | 1.630 |
Why?
|
Skin Transplantation | 7 | 2019 | 1074 | 1.610 |
Why?
|
Heart Transplantation | 17 | 2021 | 3112 | 1.580 |
Why?
|
Transplantation Tolerance | 9 | 2021 | 617 | 1.510 |
Why?
|
Infertility, Female | 6 | 2022 | 788 | 1.420 |
Why?
|
Antilymphocyte Serum | 14 | 2020 | 492 | 1.410 |
Why?
|
Tissue and Organ Harvesting | 13 | 2021 | 369 | 1.410 |
Why?
|
Kidney | 46 | 2024 | 7184 | 1.320 |
Why?
|
Liver Transplantation | 39 | 2021 | 2119 | 1.240 |
Why?
|
Adaptive Immunity | 5 | 2019 | 714 | 1.220 |
Why?
|
Facial Injuries | 4 | 2015 | 183 | 1.180 |
Why?
|
Tacrolimus | 25 | 2016 | 743 | 1.170 |
Why?
|
Cyclosporine | 25 | 2012 | 788 | 1.140 |
Why?
|
Immune System | 7 | 2021 | 806 | 1.110 |
Why?
|
Living Donors | 14 | 2022 | 621 | 1.080 |
Why?
|
Lymphocytes | 10 | 2020 | 2617 | 1.080 |
Why?
|
Heme Oxygenase (Decyclizing) | 8 | 2008 | 171 | 1.060 |
Why?
|
Tissue Transplantation | 3 | 2016 | 130 | 1.030 |
Why?
|
Taurodeoxycholic Acid | 2 | 2021 | 13 | 1.020 |
Why?
|
T-Lymphocytes | 28 | 2021 | 10183 | 1.010 |
Why?
|
Isoantibodies | 8 | 2020 | 679 | 1.000 |
Why?
|
Mice, Inbred DBA | 7 | 2021 | 642 | 1.000 |
Why?
|
Primary Graft Dysfunction | 2 | 2022 | 93 | 0.980 |
Why?
|
Perfusion | 8 | 2023 | 1360 | 0.960 |
Why?
|
CD4-Positive T-Lymphocytes | 10 | 2021 | 4386 | 0.940 |
Why?
|
Kidney Failure, Chronic | 15 | 2020 | 2535 | 0.920 |
Why?
|
T-Lymphocytes, Regulatory | 7 | 2021 | 2988 | 0.920 |
Why?
|
Animals | 139 | 2023 | 168770 | 0.910 |
Why?
|
NAD | 3 | 2018 | 590 | 0.910 |
Why?
|
Age Factors | 30 | 2021 | 18373 | 0.900 |
Why?
|
Rats | 83 | 2023 | 24252 | 0.890 |
Why?
|
Valine | 2 | 2021 | 413 | 0.870 |
Why?
|
Interleukin-10 | 3 | 2018 | 1200 | 0.820 |
Why?
|
Interferon-gamma | 12 | 2018 | 3207 | 0.820 |
Why?
|
Th17 Cells | 2 | 2020 | 766 | 0.820 |
Why?
|
Renal Insufficiency | 5 | 2013 | 804 | 0.810 |
Why?
|
Bariatric Surgery | 2 | 2021 | 952 | 0.810 |
Why?
|
Mice, Inbred C57BL | 27 | 2023 | 21833 | 0.800 |
Why?
|
Histocompatibility Testing | 8 | 2016 | 741 | 0.790 |
Why?
|
Inflammation | 15 | 2023 | 10636 | 0.750 |
Why?
|
Quercetin | 1 | 2020 | 93 | 0.720 |
Why?
|
Biomedical Research | 5 | 2020 | 3309 | 0.700 |
Why?
|
Death | 6 | 2023 | 678 | 0.680 |
Why?
|
Humans | 214 | 2024 | 744376 | 0.660 |
Why?
|
Immune Tolerance | 12 | 2023 | 2259 | 0.650 |
Why?
|
Donor Selection | 5 | 2019 | 201 | 0.650 |
Why?
|
Cold Ischemia | 4 | 2018 | 65 | 0.650 |
Why?
|
Isoantigens | 9 | 2015 | 567 | 0.610 |
Why?
|
Renal Circulation | 2 | 2013 | 334 | 0.600 |
Why?
|
Hospitals, Special | 1 | 2017 | 101 | 0.570 |
Why?
|
Lymphocyte Activation | 10 | 2021 | 5524 | 0.570 |
Why?
|
Immunologic Memory | 4 | 2019 | 1348 | 0.570 |
Why?
|
Gastrectomy | 1 | 2021 | 663 | 0.570 |
Why?
|
Nephrectomy | 10 | 2018 | 1050 | 0.560 |
Why?
|
Transplantation, Isogeneic | 13 | 2005 | 257 | 0.560 |
Why?
|
Dendritic Cells | 9 | 2020 | 2725 | 0.540 |
Why?
|
DNA, Mitochondrial | 1 | 2020 | 817 | 0.510 |
Why?
|
Protoporphyrins | 7 | 2008 | 164 | 0.510 |
Why?
|
Awards and Prizes | 2 | 2017 | 375 | 0.510 |
Why?
|
Urogenital Abnormalities | 1 | 2018 | 261 | 0.510 |
Why?
|
Metabolome | 1 | 2021 | 895 | 0.490 |
Why?
|
Periodicals as Topic | 2 | 2016 | 1431 | 0.480 |
Why?
|
Mice | 32 | 2023 | 81202 | 0.470 |
Why?
|
Writing | 1 | 2016 | 206 | 0.470 |
Why?
|
Warm Ischemia | 2 | 2012 | 53 | 0.460 |
Why?
|
Immunoconjugates | 2 | 2020 | 901 | 0.460 |
Why?
|
Interleukin-17 | 3 | 2020 | 901 | 0.450 |
Why?
|
Time Factors | 54 | 2018 | 40077 | 0.450 |
Why?
|
Fertility | 1 | 2018 | 781 | 0.440 |
Why?
|
Bibliometrics | 1 | 2017 | 339 | 0.440 |
Why?
|
Kidney Tubules, Proximal | 2 | 2024 | 416 | 0.430 |
Why?
|
Fetus | 1 | 2020 | 1880 | 0.420 |
Why?
|
Pulsatile Flow | 2 | 2011 | 332 | 0.420 |
Why?
|
Mice, Inbred BALB C | 8 | 2022 | 6387 | 0.410 |
Why?
|
Humanism | 1 | 2013 | 89 | 0.410 |
Why?
|
Organ Preservation Solutions | 4 | 2011 | 98 | 0.410 |
Why?
|
Heme Oxygenase-1 | 9 | 2007 | 381 | 0.410 |
Why?
|
Sirolimus | 3 | 2022 | 1565 | 0.410 |
Why?
|
Postoperative Complications | 22 | 2020 | 15295 | 0.400 |
Why?
|
Upper Extremity | 1 | 2016 | 648 | 0.400 |
Why?
|
Exploratory Behavior | 1 | 2013 | 270 | 0.400 |
Why?
|
Kidney Diseases | 6 | 2017 | 2148 | 0.400 |
Why?
|
History, 20th Century | 6 | 2020 | 2740 | 0.400 |
Why?
|
Lung Transplantation | 4 | 2021 | 1155 | 0.390 |
Why?
|
Cryopreservation | 4 | 2010 | 670 | 0.390 |
Why?
|
Male | 120 | 2023 | 350118 | 0.390 |
Why?
|
Frail Elderly | 1 | 2016 | 693 | 0.390 |
Why?
|
HLA Antigens | 7 | 2016 | 1382 | 0.390 |
Why?
|
Burns, Electric | 1 | 2011 | 42 | 0.380 |
Why?
|
Cytokines | 22 | 2023 | 7323 | 0.380 |
Why?
|
Ischemia | 7 | 2020 | 1907 | 0.380 |
Why?
|
Naphthalenes | 1 | 2011 | 194 | 0.380 |
Why?
|
Obesity, Morbid | 1 | 2021 | 1213 | 0.380 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2011 | 126 | 0.380 |
Why?
|
Proteinuria | 17 | 2009 | 658 | 0.370 |
Why?
|
Myelin Sheath | 1 | 2014 | 652 | 0.370 |
Why?
|
Skin Ulcer | 1 | 2011 | 120 | 0.370 |
Why?
|
Blood Vessels | 1 | 2016 | 1125 | 0.370 |
Why?
|
Steroids | 2 | 2015 | 930 | 0.360 |
Why?
|
Methylene Chloride | 2 | 2006 | 11 | 0.360 |
Why?
|
Tissue Survival | 2 | 2021 | 118 | 0.360 |
Why?
|
Editorial Policies | 1 | 2015 | 451 | 0.360 |
Why?
|
Treatment Outcome | 40 | 2021 | 63115 | 0.360 |
Why?
|
Obesity | 5 | 2023 | 12745 | 0.350 |
Why?
|
Calciphylaxis | 1 | 2011 | 124 | 0.350 |
Why?
|
Reoperation | 17 | 2010 | 4201 | 0.350 |
Why?
|
Plasmapheresis | 3 | 2014 | 211 | 0.350 |
Why?
|
Regional Blood Flow | 1 | 2013 | 1525 | 0.350 |
Why?
|
Transplants | 2 | 2021 | 209 | 0.340 |
Why?
|
Parathyroidectomy | 1 | 2011 | 235 | 0.340 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2024 | 2200 | 0.340 |
Why?
|
Cell Communication | 2 | 2016 | 1621 | 0.340 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2014 | 1369 | 0.340 |
Why?
|
Th1 Cells | 3 | 2019 | 1057 | 0.330 |
Why?
|
Adoptive Transfer | 5 | 2016 | 844 | 0.330 |
Why?
|
T-Lymphocyte Subsets | 2 | 2017 | 1837 | 0.330 |
Why?
|
Carbon Monoxide | 4 | 2007 | 531 | 0.330 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2014 | 834 | 0.330 |
Why?
|
History, 21st Century | 4 | 2020 | 1534 | 0.330 |
Why?
|
Regeneration | 2 | 2014 | 1485 | 0.330 |
Why?
|
Wnt Proteins | 1 | 2012 | 721 | 0.320 |
Why?
|
Forkhead Transcription Factors | 1 | 2016 | 1613 | 0.320 |
Why?
|
Recombinant Fusion Proteins | 6 | 2013 | 3773 | 0.320 |
Why?
|
Flow Cytometry | 11 | 2018 | 5974 | 0.310 |
Why?
|
Desensitization, Immunologic | 2 | 2014 | 483 | 0.310 |
Why?
|
Aged | 44 | 2023 | 163284 | 0.310 |
Why?
|
Liver Failure | 2 | 2007 | 241 | 0.310 |
Why?
|
CD40 Ligand | 2 | 2022 | 526 | 0.310 |
Why?
|
Risk Factors | 31 | 2020 | 72295 | 0.310 |
Why?
|
Ischemic Preconditioning | 1 | 2008 | 92 | 0.310 |
Why?
|
Antibodies, Monoclonal | 14 | 2017 | 9274 | 0.300 |
Why?
|
Quality Assurance, Health Care | 1 | 2018 | 2212 | 0.300 |
Why?
|
Mycophenolic Acid | 7 | 2015 | 343 | 0.300 |
Why?
|
Lymph Nodes | 6 | 2023 | 3475 | 0.300 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2018 | 4479 | 0.290 |
Why?
|
Antibody Formation | 3 | 2008 | 1402 | 0.290 |
Why?
|
Waiting Lists | 4 | 2021 | 692 | 0.290 |
Why?
|
Societies, Medical | 6 | 2020 | 3743 | 0.280 |
Why?
|
Inflammation Mediators | 2 | 2015 | 1888 | 0.280 |
Why?
|
Female | 81 | 2023 | 380200 | 0.270 |
Why?
|
Chronic Disease | 34 | 2017 | 9145 | 0.270 |
Why?
|
Gender Identity | 2 | 2023 | 687 | 0.270 |
Why?
|
Informed Consent | 1 | 2012 | 995 | 0.260 |
Why?
|
Face | 3 | 2019 | 994 | 0.260 |
Why?
|
Bone Marrow Transplantation | 1 | 2013 | 2765 | 0.250 |
Why?
|
Cell Differentiation | 4 | 2020 | 11486 | 0.250 |
Why?
|
ABO Blood-Group System | 1 | 2007 | 367 | 0.250 |
Why?
|
Middle Aged | 63 | 2020 | 213388 | 0.250 |
Why?
|
Carbon Monoxide Poisoning | 1 | 2005 | 66 | 0.240 |
Why?
|
Immunity | 2 | 2022 | 1014 | 0.240 |
Why?
|
Adult | 62 | 2024 | 214056 | 0.240 |
Why?
|
Mycoses | 1 | 2007 | 376 | 0.240 |
Why?
|
Th2 Cells | 2 | 2019 | 1061 | 0.240 |
Why?
|
Transplantation Conditioning | 3 | 2022 | 1599 | 0.230 |
Why?
|
Patient Selection | 6 | 2020 | 4216 | 0.230 |
Why?
|
Burns | 1 | 2015 | 1815 | 0.230 |
Why?
|
Models, Animal | 7 | 2017 | 2173 | 0.220 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2021 | 2540 | 0.220 |
Why?
|
Surgical Procedures, Operative | 1 | 2015 | 1876 | 0.220 |
Why?
|
Skin | 4 | 2021 | 4371 | 0.220 |
Why?
|
Raffinose | 1 | 2002 | 52 | 0.220 |
Why?
|
Enzyme Induction | 5 | 2005 | 475 | 0.220 |
Why?
|
Antibodies | 5 | 2016 | 2460 | 0.220 |
Why?
|
Health Status | 1 | 2016 | 4033 | 0.220 |
Why?
|
Antifungal Agents | 1 | 2007 | 729 | 0.210 |
Why?
|
Cobalt | 1 | 2002 | 158 | 0.210 |
Why?
|
Kidney Function Tests | 5 | 2016 | 683 | 0.210 |
Why?
|
Methylprednisolone | 4 | 2009 | 387 | 0.200 |
Why?
|
Aging, Premature | 1 | 2021 | 47 | 0.200 |
Why?
|
Disease Models, Animal | 9 | 2021 | 18034 | 0.200 |
Why?
|
Live Birth | 3 | 2022 | 512 | 0.200 |
Why?
|
Intercellular Adhesion Molecule-1 | 12 | 2010 | 1159 | 0.190 |
Why?
|
Allopurinol | 1 | 2002 | 191 | 0.190 |
Why?
|
Receptors, Interleukin-2 | 5 | 2003 | 573 | 0.190 |
Why?
|
Injections, Intraperitoneal | 1 | 2021 | 425 | 0.190 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5445 | 0.190 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 3 | 2021 | 310 | 0.190 |
Why?
|
Mice, Obese | 1 | 2021 | 425 | 0.180 |
Why?
|
46, XX Disorders of Sex Development | 1 | 2020 | 31 | 0.180 |
Why?
|
Gene Expression Profiling | 5 | 2021 | 9445 | 0.180 |
Why?
|
Complement System Proteins | 2 | 2014 | 795 | 0.180 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2023 | 256 | 0.180 |
Why?
|
Receptors, Leptin | 1 | 2022 | 361 | 0.180 |
Why?
|
Adrenocorticotropic Hormone | 2 | 2021 | 648 | 0.180 |
Why?
|
Interleukin-6 | 6 | 2018 | 3203 | 0.180 |
Why?
|
Preoperative Care | 3 | 2010 | 2250 | 0.180 |
Why?
|
Medication Adherence | 1 | 2011 | 2063 | 0.180 |
Why?
|
Glutathione | 1 | 2002 | 590 | 0.180 |
Why?
|
Ureteral Obstruction | 1 | 2021 | 296 | 0.180 |
Why?
|
Multiple Sclerosis | 1 | 2014 | 3079 | 0.180 |
Why?
|
Cells, Cultured | 7 | 2017 | 19233 | 0.180 |
Why?
|
Gene Expression | 7 | 2018 | 7798 | 0.170 |
Why?
|
Mullerian Ducts | 1 | 2020 | 198 | 0.170 |
Why?
|
Risk Assessment | 10 | 2019 | 23336 | 0.170 |
Why?
|
Mice, Knockout | 6 | 2017 | 14561 | 0.170 |
Why?
|
Carrier Proteins | 1 | 2012 | 5023 | 0.170 |
Why?
|
End Stage Liver Disease | 1 | 2023 | 314 | 0.170 |
Why?
|
Sex Characteristics | 4 | 2019 | 2585 | 0.170 |
Why?
|
Wounds and Injuries | 1 | 2011 | 2400 | 0.170 |
Why?
|
Glucose Intolerance | 1 | 2023 | 577 | 0.170 |
Why?
|
Liver | 7 | 2021 | 7475 | 0.170 |
Why?
|
Hyperammonemia | 1 | 2019 | 76 | 0.160 |
Why?
|
United States | 17 | 2022 | 69869 | 0.160 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 9 | 2010 | 4751 | 0.160 |
Why?
|
Signal Transduction | 6 | 2022 | 23406 | 0.160 |
Why?
|
Hand-Assisted Laparoscopy | 1 | 2018 | 16 | 0.160 |
Why?
|
Gift Giving | 1 | 2018 | 80 | 0.160 |
Why?
|
Follow-Up Studies | 30 | 2023 | 39052 | 0.160 |
Why?
|
Embryo Implantation | 1 | 2020 | 272 | 0.160 |
Why?
|
Interleukins | 4 | 2009 | 791 | 0.160 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2023 | 985 | 0.160 |
Why?
|
Resource Allocation | 1 | 2020 | 341 | 0.160 |
Why?
|
Antigen Presentation | 2 | 2021 | 1284 | 0.160 |
Why?
|
Class Ib Phosphatidylinositol 3-Kinase | 1 | 2017 | 30 | 0.150 |
Why?
|
Primates | 1 | 2020 | 545 | 0.150 |
Why?
|
Retroperitoneal Space | 1 | 2018 | 176 | 0.150 |
Why?
|
Survival Analysis | 13 | 2014 | 10252 | 0.150 |
Why?
|
Myeloid Cells | 1 | 2022 | 810 | 0.150 |
Why?
|
Adenosine | 1 | 2002 | 825 | 0.150 |
Why?
|
Cold Temperature | 3 | 2010 | 772 | 0.150 |
Why?
|
Lymphocyte Transfusion | 1 | 1998 | 236 | 0.150 |
Why?
|
Cytomegalovirus Infections | 3 | 2012 | 820 | 0.150 |
Why?
|
Estradiol | 2 | 2021 | 2020 | 0.150 |
Why?
|
Histocompatibility | 2 | 2017 | 330 | 0.140 |
Why?
|
Altruism | 1 | 2018 | 204 | 0.140 |
Why?
|
Receptors, Natural Killer Cell | 1 | 2016 | 57 | 0.140 |
Why?
|
HLA-DR1 Antigen | 1 | 2016 | 12 | 0.140 |
Why?
|
Genes, T-Cell Receptor | 1 | 2016 | 29 | 0.140 |
Why?
|
Gene Expression Regulation | 9 | 2021 | 12073 | 0.140 |
Why?
|
Thalidomide | 1 | 2021 | 890 | 0.140 |
Why?
|
Stromal Cells | 1 | 2022 | 1355 | 0.140 |
Why?
|
Cell Movement | 6 | 2018 | 5218 | 0.140 |
Why?
|
Interleukin-2 Receptor beta Subunit | 1 | 2016 | 24 | 0.140 |
Why?
|
Acute Disease | 11 | 2017 | 7147 | 0.140 |
Why?
|
Chemokine CCL3 | 1 | 2016 | 84 | 0.140 |
Why?
|
International Cooperation | 3 | 2020 | 1420 | 0.130 |
Why?
|
Prednisolone | 6 | 2003 | 334 | 0.130 |
Why?
|
Histocompatibility Antigens Class II | 6 | 2005 | 1475 | 0.130 |
Why?
|
Pregnancy | 5 | 2022 | 29144 | 0.130 |
Why?
|
Congresses as Topic | 1 | 2020 | 764 | 0.130 |
Why?
|
Pancreas | 1 | 2002 | 1687 | 0.130 |
Why?
|
Congenital Abnormalities | 1 | 2020 | 707 | 0.130 |
Why?
|
Mice, Inbred CBA | 1 | 2016 | 448 | 0.130 |
Why?
|
Drug Delivery Systems | 2 | 2017 | 2219 | 0.130 |
Why?
|
Mice, Transgenic | 4 | 2018 | 9735 | 0.130 |
Why?
|
Monitoring, Immunologic | 1 | 2015 | 100 | 0.120 |
Why?
|
Hepatectomy | 4 | 2014 | 550 | 0.120 |
Why?
|
Antigens | 2 | 2016 | 1466 | 0.120 |
Why?
|
Receptors, Interleukin-6 | 1 | 2016 | 225 | 0.120 |
Why?
|
Tryptophan Hydroxylase | 1 | 2014 | 89 | 0.120 |
Why?
|
Killer Cells, Natural | 3 | 2016 | 2133 | 0.120 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2018 | 476 | 0.120 |
Why?
|
Ferrosoferric Oxide | 1 | 2016 | 360 | 0.120 |
Why?
|
Hyperglycemia | 1 | 2023 | 1373 | 0.120 |
Why?
|
Cell Adhesion Molecules | 8 | 1994 | 1602 | 0.120 |
Why?
|
Anastomosis, Surgical | 2 | 2010 | 987 | 0.120 |
Why?
|
Homeostasis | 2 | 2016 | 3339 | 0.120 |
Why?
|
Amputees | 1 | 2014 | 75 | 0.120 |
Why?
|
Endothelium, Vascular | 3 | 2018 | 4458 | 0.120 |
Why?
|
Graft vs Host Reaction | 1 | 2014 | 104 | 0.120 |
Why?
|
Blood Loss, Surgical | 1 | 2018 | 662 | 0.120 |
Why?
|
Immunoglobulins | 3 | 2012 | 881 | 0.120 |
Why?
|
Phenotype | 3 | 2019 | 16367 | 0.120 |
Why?
|
Genes, Reporter | 1 | 2018 | 1547 | 0.120 |
Why?
|
Health Status Disparities | 2 | 2019 | 1796 | 0.120 |
Why?
|
MicroRNAs | 4 | 2016 | 3751 | 0.110 |
Why?
|
Allergy and Immunology | 1 | 2015 | 169 | 0.110 |
Why?
|
Vascular Grafting | 1 | 2015 | 143 | 0.110 |
Why?
|
Capillaries | 1 | 2016 | 773 | 0.110 |
Why?
|
Cell Adhesion | 3 | 2010 | 3144 | 0.110 |
Why?
|
Consensus | 2 | 2020 | 2960 | 0.110 |
Why?
|
Complement Activation | 2 | 2012 | 453 | 0.110 |
Why?
|
Clinical Trials as Topic | 3 | 2019 | 7914 | 0.110 |
Why?
|
Brazil | 1 | 2017 | 1270 | 0.110 |
Why?
|
DNA | 2 | 2023 | 7294 | 0.110 |
Why?
|
Diffusion of Innovation | 1 | 2018 | 725 | 0.110 |
Why?
|
Surgical Wound Infection | 2 | 2012 | 1540 | 0.110 |
Why?
|
Informed Consent By Minors | 1 | 2012 | 7 | 0.110 |
Why?
|
Mechanotransduction, Cellular | 1 | 2018 | 541 | 0.110 |
Why?
|
Polymers | 1 | 2020 | 1621 | 0.110 |
Why?
|
Prognosis | 13 | 2019 | 29060 | 0.110 |
Why?
|
Europe | 2 | 2021 | 3339 | 0.110 |
Why?
|
Delayed Graft Function | 2 | 2010 | 48 | 0.110 |
Why?
|
Glucocorticoids | 4 | 2011 | 2108 | 0.110 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3135 | 0.110 |
Why?
|
Transplantation Chimera | 2 | 2013 | 613 | 0.110 |
Why?
|
Reactive Oxygen Species | 1 | 2020 | 2076 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3242 | 0.100 |
Why?
|
Hepatitis B | 4 | 2002 | 695 | 0.100 |
Why?
|
Rats, Inbred Strains | 3 | 2009 | 2186 | 0.100 |
Why?
|
Anesthesia | 2 | 2014 | 1560 | 0.100 |
Why?
|
Tumor Necrosis Factor-alpha | 7 | 2020 | 4424 | 0.100 |
Why?
|
Hemodynamics | 2 | 2012 | 4196 | 0.100 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2011 | 130 | 0.100 |
Why?
|
Seasons | 1 | 2017 | 1493 | 0.100 |
Why?
|
Vacuolar Proton-Translocating ATPases | 2 | 2006 | 195 | 0.100 |
Why?
|
Access to Information | 1 | 2015 | 320 | 0.100 |
Why?
|
Immunohistochemistry | 12 | 2014 | 11366 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 6 | 2020 | 2214 | 0.100 |
Why?
|
Lymphocyte Depletion | 1 | 2013 | 608 | 0.100 |
Why?
|
Endocrine System | 1 | 2012 | 113 | 0.100 |
Why?
|
Registries | 4 | 2020 | 8091 | 0.100 |
Why?
|
Intestines | 1 | 2020 | 1924 | 0.100 |
Why?
|
Laboratories | 1 | 2015 | 463 | 0.100 |
Why?
|
Rats, Inbred BN | 2 | 2002 | 235 | 0.100 |
Why?
|
Antigens, CD | 7 | 2012 | 4026 | 0.100 |
Why?
|
Patient Preference | 1 | 2018 | 889 | 0.090 |
Why?
|
Rosacea | 1 | 2011 | 49 | 0.090 |
Why?
|
Insulin | 3 | 2002 | 6582 | 0.090 |
Why?
|
Uremia | 1 | 2011 | 200 | 0.090 |
Why?
|
Mast Cells | 1 | 2018 | 1544 | 0.090 |
Why?
|
Immunocompetence | 1 | 2010 | 136 | 0.090 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2014 | 1335 | 0.090 |
Why?
|
Immunocompromised Host | 1 | 2015 | 847 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2019 | 2110 | 0.090 |
Why?
|
Liver Neoplasms | 7 | 2020 | 4253 | 0.090 |
Why?
|
Weight Loss | 1 | 2021 | 2625 | 0.090 |
Why?
|
Thigh | 1 | 2011 | 247 | 0.090 |
Why?
|
Healthcare Disparities | 2 | 2019 | 3154 | 0.090 |
Why?
|
Procaine | 1 | 2010 | 60 | 0.090 |
Why?
|
Heat-Shock Proteins | 1 | 2014 | 822 | 0.090 |
Why?
|
Phagocytosis | 1 | 2016 | 1539 | 0.090 |
Why?
|
Lymphocele | 1 | 2009 | 16 | 0.090 |
Why?
|
Cadaver | 3 | 2010 | 1337 | 0.090 |
Why?
|
Blood Group Incompatibility | 1 | 2010 | 146 | 0.090 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2012 | 906 | 0.090 |
Why?
|
Lipids | 1 | 2021 | 3307 | 0.090 |
Why?
|
Complement C3 | 2 | 2010 | 461 | 0.090 |
Why?
|
Personal Autonomy | 1 | 2012 | 298 | 0.090 |
Why?
|
Drug Therapy, Combination | 12 | 2005 | 6489 | 0.090 |
Why?
|
Potassium Chloride | 1 | 2010 | 237 | 0.090 |
Why?
|
Berlin | 1 | 2009 | 23 | 0.090 |
Why?
|
RNA, Messenger | 10 | 2010 | 13035 | 0.090 |
Why?
|
Membrane Proteins | 4 | 2021 | 7882 | 0.090 |
Why?
|
Acute Kidney Injury | 2 | 2016 | 1968 | 0.090 |
Why?
|
BK Virus | 1 | 2010 | 129 | 0.090 |
Why?
|
Mannitol | 1 | 2010 | 181 | 0.080 |
Why?
|
Ubiquitin | 1 | 2014 | 851 | 0.080 |
Why?
|
Pancreas Transplantation | 1 | 2010 | 187 | 0.080 |
Why?
|
Creatinine | 7 | 2016 | 1919 | 0.080 |
Why?
|
Neovascularization, Physiologic | 1 | 2016 | 1351 | 0.080 |
Why?
|
Isoflurane | 1 | 2012 | 380 | 0.080 |
Why?
|
Forecasting | 1 | 2018 | 2951 | 0.080 |
Why?
|
Lectins, C-Type | 1 | 2012 | 589 | 0.080 |
Why?
|
Motivation | 1 | 2018 | 1971 | 0.080 |
Why?
|
Epithelial Cells | 3 | 2024 | 3690 | 0.080 |
Why?
|
Multivariate Analysis | 3 | 2011 | 12244 | 0.080 |
Why?
|
Liver Cirrhosis | 5 | 2002 | 1862 | 0.080 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2014 | 652 | 0.080 |
Why?
|
Geriatric Assessment | 1 | 2016 | 1372 | 0.080 |
Why?
|
Fluoroquinolones | 1 | 2010 | 310 | 0.080 |
Why?
|
Polyomavirus Infections | 1 | 2010 | 200 | 0.080 |
Why?
|
Ureter | 1 | 2010 | 375 | 0.080 |
Why?
|
Cadherins | 1 | 2012 | 907 | 0.080 |
Why?
|
Leadership | 1 | 2017 | 1357 | 0.080 |
Why?
|
Retrospective Studies | 30 | 2021 | 77459 | 0.080 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2017 | 2938 | 0.080 |
Why?
|
Fibroblasts | 2 | 2022 | 4162 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2016 | 1620 | 0.080 |
Why?
|
Boronic Acids | 1 | 2012 | 965 | 0.080 |
Why?
|
beta Catenin | 1 | 2012 | 1059 | 0.070 |
Why?
|
Ventilator Weaning | 1 | 2008 | 148 | 0.070 |
Why?
|
Predictive Value of Tests | 4 | 2015 | 15078 | 0.070 |
Why?
|
Protein Subunits | 2 | 2003 | 959 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 2 | 2008 | 1790 | 0.070 |
Why?
|
Necrosis | 1 | 2011 | 1643 | 0.070 |
Why?
|
Common Bile Duct | 1 | 2007 | 109 | 0.070 |
Why?
|
Erythrocyte Transfusion | 1 | 2011 | 565 | 0.070 |
Why?
|
Residence Characteristics | 1 | 2017 | 2050 | 0.070 |
Why?
|
Germany | 1 | 2009 | 862 | 0.070 |
Why?
|
Carboxyhemoglobin | 1 | 2006 | 81 | 0.070 |
Why?
|
Immunologic Factors | 1 | 2016 | 1580 | 0.070 |
Why?
|
Endothelium | 2 | 2022 | 778 | 0.070 |
Why?
|
Antigens, Surface | 3 | 2016 | 1663 | 0.070 |
Why?
|
Receptors, Chemokine | 1 | 2010 | 670 | 0.070 |
Why?
|
Lung | 2 | 2022 | 9857 | 0.070 |
Why?
|
Duodenal Diseases | 1 | 2007 | 102 | 0.070 |
Why?
|
Lymphocyte Subsets | 2 | 1998 | 315 | 0.070 |
Why?
|
Muromegalovirus | 1 | 2006 | 31 | 0.070 |
Why?
|
Treatment Failure | 2 | 2002 | 2618 | 0.070 |
Why?
|
Contrast Media | 3 | 2016 | 5300 | 0.070 |
Why?
|
Immunologic Techniques | 2 | 2003 | 219 | 0.070 |
Why?
|
Information Dissemination | 1 | 2015 | 1099 | 0.070 |
Why?
|
Homeodomain Proteins | 1 | 2016 | 2418 | 0.070 |
Why?
|
Autophagy | 1 | 2014 | 1297 | 0.070 |
Why?
|
Oligonucleotides, Antisense | 2 | 1998 | 433 | 0.070 |
Why?
|
Cholangitis | 1 | 2007 | 108 | 0.070 |
Why?
|
Ketamine | 1 | 2012 | 501 | 0.070 |
Why?
|
Glomerular Filtration Rate | 5 | 2020 | 2166 | 0.070 |
Why?
|
Surgical Flaps | 1 | 2015 | 1640 | 0.070 |
Why?
|
Blood Coagulation | 1 | 2012 | 1127 | 0.070 |
Why?
|
Diverticulum | 1 | 2007 | 136 | 0.070 |
Why?
|
Pyrazines | 1 | 2012 | 1230 | 0.070 |
Why?
|
Azathioprine | 4 | 2000 | 354 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2010 | 3873 | 0.070 |
Why?
|
Transforming Growth Factor beta | 3 | 2021 | 2007 | 0.070 |
Why?
|
Bacterial Infections | 3 | 2002 | 1401 | 0.070 |
Why?
|
Nanoparticles | 1 | 2017 | 1905 | 0.070 |
Why?
|
Boston | 3 | 2014 | 9312 | 0.070 |
Why?
|
Bone Marrow Cells | 1 | 2013 | 2513 | 0.070 |
Why?
|
Wound Healing | 1 | 2016 | 2785 | 0.060 |
Why?
|
Young Adult | 7 | 2018 | 56434 | 0.060 |
Why?
|
Health Care Costs | 1 | 2018 | 3209 | 0.060 |
Why?
|
Toll-Like Receptors | 1 | 2008 | 593 | 0.060 |
Why?
|
Hemoperfusion | 1 | 2004 | 14 | 0.060 |
Why?
|
Actins | 1 | 2012 | 2121 | 0.060 |
Why?
|
Infusions, Intravenous | 1 | 2010 | 2274 | 0.060 |
Why?
|
Cohort Studies | 5 | 2018 | 40558 | 0.060 |
Why?
|
Macrophages | 8 | 2003 | 5660 | 0.060 |
Why?
|
Bilirubin | 2 | 2004 | 425 | 0.060 |
Why?
|
Hyperbilirubinemia | 1 | 2004 | 77 | 0.060 |
Why?
|
Pandemics | 5 | 2022 | 8386 | 0.060 |
Why?
|
Survival Rate | 13 | 2013 | 12788 | 0.060 |
Why?
|
Angiography, Digital Subtraction | 1 | 2005 | 341 | 0.060 |
Why?
|
Bacterial Translocation | 1 | 2004 | 73 | 0.060 |
Why?
|
Antiviral Agents | 2 | 2010 | 2987 | 0.060 |
Why?
|
Perception | 1 | 2010 | 1198 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 3922 | 0.060 |
Why?
|
Lymphocyte Count | 2 | 2003 | 793 | 0.060 |
Why?
|
Hepatitis, Autoimmune | 1 | 2005 | 141 | 0.060 |
Why?
|
Stem Cells | 1 | 2016 | 3567 | 0.060 |
Why?
|
Mice, Nude | 1 | 2010 | 3689 | 0.060 |
Why?
|
Minority Groups | 1 | 2010 | 1220 | 0.060 |
Why?
|
Drug Administration Schedule | 4 | 2005 | 4933 | 0.060 |
Why?
|
Caroli Disease | 1 | 2002 | 12 | 0.060 |
Why?
|
Recovery of Function | 1 | 2013 | 2926 | 0.060 |
Why?
|
Budd-Chiari Syndrome | 1 | 2002 | 25 | 0.050 |
Why?
|
Hypertension, Renal | 1 | 2003 | 177 | 0.050 |
Why?
|
Interleukin-2 | 3 | 2008 | 1904 | 0.050 |
Why?
|
Infant, Newborn | 2 | 2022 | 25628 | 0.050 |
Why?
|
Hepatitis, Viral, Human | 1 | 2002 | 138 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5321 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2003 | 251 | 0.050 |
Why?
|
2-Aminopurine | 1 | 2001 | 13 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2012 | 2916 | 0.050 |
Why?
|
Goiter, Nodular | 1 | 2001 | 24 | 0.050 |
Why?
|
Rats, Inbred WF | 3 | 1998 | 140 | 0.050 |
Why?
|
Hypotension | 1 | 2008 | 884 | 0.050 |
Why?
|
Simvastatin | 2 | 2018 | 360 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2017 | 57776 | 0.050 |
Why?
|
Dendritic Cells, Follicular | 1 | 2022 | 53 | 0.050 |
Why?
|
Patient Readmission | 1 | 2016 | 3116 | 0.050 |
Why?
|
Freezing | 1 | 2002 | 303 | 0.050 |
Why?
|
Synaptic Transmission | 1 | 2008 | 1178 | 0.050 |
Why?
|
Renal Artery | 3 | 2016 | 399 | 0.050 |
Why?
|
Metabolic Diseases | 2 | 1999 | 658 | 0.050 |
Why?
|
Child | 5 | 2021 | 77708 | 0.050 |
Why?
|
Kruppel-Like Transcription Factors | 2 | 2018 | 504 | 0.050 |
Why?
|
Venules | 1 | 2022 | 165 | 0.050 |
Why?
|
Myoblasts | 1 | 2023 | 238 | 0.050 |
Why?
|
Dystrophin | 1 | 2023 | 285 | 0.050 |
Why?
|
Blood Pressure | 4 | 2012 | 8551 | 0.050 |
Why?
|
Ice | 1 | 2002 | 104 | 0.050 |
Why?
|
Blood Transfusion | 1 | 2008 | 1301 | 0.050 |
Why?
|
Crystallization | 1 | 2002 | 525 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4666 | 0.050 |
Why?
|
Comorbidity | 1 | 2015 | 10388 | 0.050 |
Why?
|
Adolescent | 10 | 2014 | 85784 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2014 | 3020 | 0.050 |
Why?
|
Pituitary Hormones | 1 | 2002 | 183 | 0.050 |
Why?
|
Hyperthermia, Induced | 1 | 2004 | 403 | 0.050 |
Why?
|
STAT5 Transcription Factor | 1 | 2021 | 259 | 0.050 |
Why?
|
Membrane Glycoproteins | 2 | 2021 | 3771 | 0.050 |
Why?
|
Kidney Tubules | 3 | 2010 | 488 | 0.050 |
Why?
|
Probiotics | 1 | 2004 | 351 | 0.050 |
Why?
|
Prednisone | 1 | 2005 | 1574 | 0.050 |
Why?
|
Interleukin-12 | 1 | 2003 | 580 | 0.050 |
Why?
|
Extracellular Matrix | 2 | 2022 | 1741 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2003 | 595 | 0.050 |
Why?
|
Propionates | 1 | 2000 | 169 | 0.050 |
Why?
|
Enzyme Inhibitors | 2 | 2008 | 3799 | 0.040 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2003 | 659 | 0.040 |
Why?
|
Liver Function Tests | 4 | 2005 | 528 | 0.040 |
Why?
|
C-Peptide | 2 | 1999 | 419 | 0.040 |
Why?
|
Pancreatitis | 1 | 2007 | 1092 | 0.040 |
Why?
|
Angiography | 1 | 2005 | 1639 | 0.040 |
Why?
|
Cholestasis, Extrahepatic | 1 | 1999 | 51 | 0.040 |
Why?
|
Hepatic Duct, Common | 1 | 1999 | 50 | 0.040 |
Why?
|
Follicle Stimulating Hormone | 1 | 2002 | 744 | 0.040 |
Why?
|
Belgium | 1 | 2019 | 103 | 0.040 |
Why?
|
Animals, Newborn | 1 | 2005 | 2726 | 0.040 |
Why?
|
Proportional Hazards Models | 2 | 2011 | 12356 | 0.040 |
Why?
|
Radiographic Image Enhancement | 2 | 2016 | 885 | 0.040 |
Why?
|
Luteinizing Hormone | 1 | 2002 | 869 | 0.040 |
Why?
|
Financing, Organized | 1 | 2020 | 202 | 0.040 |
Why?
|
Pituitary Gland | 1 | 2002 | 665 | 0.040 |
Why?
|
Common Bile Duct Neoplasms | 1 | 1999 | 111 | 0.040 |
Why?
|
Cell Proliferation | 2 | 2016 | 10484 | 0.040 |
Why?
|
Fibrosis | 3 | 2021 | 2029 | 0.040 |
Why?
|
Prevalence | 2 | 2013 | 15221 | 0.040 |
Why?
|
Cognition | 1 | 2016 | 6770 | 0.040 |
Why?
|
Muromonab-CD3 | 1 | 1998 | 96 | 0.040 |
Why?
|
Recurrence | 5 | 2017 | 8340 | 0.040 |
Why?
|
Creatine | 1 | 2000 | 421 | 0.040 |
Why?
|
Major Histocompatibility Complex | 1 | 2001 | 936 | 0.040 |
Why?
|
Transplantation, Heterotopic | 1 | 2018 | 175 | 0.040 |
Why?
|
Crosses, Genetic | 1 | 1999 | 791 | 0.040 |
Why?
|
Glucose | 1 | 2010 | 4398 | 0.040 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2002 | 1213 | 0.040 |
Why?
|
Lymphatic Vessels | 1 | 2022 | 353 | 0.040 |
Why?
|
Sex Factors | 2 | 2023 | 10400 | 0.040 |
Why?
|
DNA, Complementary | 3 | 2007 | 2050 | 0.040 |
Why?
|
Hormones | 1 | 2021 | 889 | 0.040 |
Why?
|
Listeriosis | 1 | 2018 | 149 | 0.040 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 2 | 1995 | 379 | 0.040 |
Why?
|
Liver Failure, Acute | 1 | 1998 | 165 | 0.040 |
Why?
|
Incidence | 7 | 2020 | 20950 | 0.030 |
Why?
|
Body Mass Index | 2 | 2011 | 12720 | 0.030 |
Why?
|
Transcription, Genetic | 3 | 2010 | 7722 | 0.030 |
Why?
|
Thyroidectomy | 1 | 2001 | 879 | 0.030 |
Why?
|
Listeria monocytogenes | 1 | 2018 | 250 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2012 | 20130 | 0.030 |
Why?
|
Sweden | 1 | 2019 | 1346 | 0.030 |
Why?
|
China | 1 | 2022 | 2245 | 0.030 |
Why?
|
Postoperative Period | 3 | 2008 | 1842 | 0.030 |
Why?
|
Colon | 1 | 2004 | 1772 | 0.030 |
Why?
|
Virus Diseases | 1 | 2002 | 711 | 0.030 |
Why?
|
Censuses | 1 | 2017 | 200 | 0.030 |
Why?
|
Research Personnel | 1 | 2020 | 573 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 2 | 2002 | 1856 | 0.030 |
Why?
|
Cell Line | 2 | 2022 | 16000 | 0.030 |
Why?
|
Biopsy | 3 | 2013 | 6755 | 0.030 |
Why?
|
Viral Proteins | 1 | 2003 | 1900 | 0.030 |
Why?
|
Health Care Rationing | 1 | 2018 | 437 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 3505 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 5 | 2004 | 8300 | 0.030 |
Why?
|
Transplantation, Autologous | 2 | 2016 | 2124 | 0.030 |
Why?
|
Internationality | 1 | 2020 | 1002 | 0.030 |
Why?
|
DNA, Viral | 1 | 2001 | 2227 | 0.030 |
Why?
|
Antigens, CD34 | 1 | 2016 | 659 | 0.030 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2019 | 482 | 0.030 |
Why?
|
Polyesters | 1 | 2016 | 363 | 0.030 |
Why?
|
Hysterectomy | 1 | 2020 | 927 | 0.030 |
Why?
|
Stomach Neoplasms | 1 | 2004 | 1332 | 0.030 |
Why?
|
Blotting, Western | 3 | 2010 | 5181 | 0.030 |
Why?
|
Rabbits | 2 | 2011 | 4894 | 0.030 |
Why?
|
Blood Glucose | 2 | 1999 | 6254 | 0.030 |
Why?
|
Organ Size | 3 | 2012 | 2251 | 0.030 |
Why?
|
Occupational Health | 1 | 2020 | 808 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2011 | 3508 | 0.030 |
Why?
|
Mutation | 2 | 2017 | 29786 | 0.030 |
Why?
|
Jejunostomy | 2 | 2007 | 57 | 0.030 |
Why?
|
Antigens, CD20 | 1 | 2014 | 199 | 0.030 |
Why?
|
Binding, Competitive | 1 | 1995 | 1157 | 0.030 |
Why?
|
Bile Duct Neoplasms | 1 | 1999 | 567 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2016 | 547 | 0.030 |
Why?
|
Combined Modality Therapy | 3 | 2014 | 8642 | 0.030 |
Why?
|
Thermosensing | 1 | 2013 | 56 | 0.030 |
Why?
|
Kidney Glomerulus | 4 | 1999 | 697 | 0.030 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2017 | 890 | 0.030 |
Why?
|
Microspheres | 1 | 2016 | 777 | 0.030 |
Why?
|
Nephrons | 1 | 1994 | 220 | 0.030 |
Why?
|
Vaccines | 1 | 2002 | 823 | 0.030 |
Why?
|
Carcinoma, Renal Cell | 1 | 2008 | 3143 | 0.030 |
Why?
|
Prospective Studies | 7 | 2021 | 53291 | 0.030 |
Why?
|
Hydrogen Peroxide | 1 | 2016 | 730 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2019 | 950 | 0.030 |
Why?
|
Organizational Objectives | 1 | 2015 | 438 | 0.030 |
Why?
|
Receptors, Immunologic | 2 | 2016 | 1423 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2017 | 1656 | 0.030 |
Why?
|
Stress, Mechanical | 1 | 2018 | 1686 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2016 | 1341 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 2 | 2014 | 2505 | 0.030 |
Why?
|
Models, Immunological | 1 | 1995 | 527 | 0.030 |
Why?
|
Radioisotope Renography | 1 | 2012 | 62 | 0.030 |
Why?
|
Receptors, Progesterone | 1 | 1997 | 1098 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2016 | 2086 | 0.030 |
Why?
|
Carcinoma | 1 | 2004 | 2375 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2018 | 944 | 0.030 |
Why?
|
Quality of Life | 3 | 2021 | 12803 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2014 | 6539 | 0.030 |
Why?
|
Graft Occlusion, Vascular | 1 | 1995 | 549 | 0.030 |
Why?
|
Exosomes | 1 | 2016 | 417 | 0.030 |
Why?
|
Atrophy | 2 | 1994 | 1584 | 0.030 |
Why?
|
Length of Stay | 2 | 2018 | 6311 | 0.030 |
Why?
|
Receptors, CXCR4 | 1 | 2016 | 727 | 0.030 |
Why?
|
Hepatitis C, Chronic | 1 | 2020 | 1031 | 0.020 |
Why?
|
Immunoenzyme Techniques | 2 | 2010 | 1799 | 0.020 |
Why?
|
Pyrimidines | 2 | 2000 | 2943 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 1 | 1994 | 675 | 0.020 |
Why?
|
Chemokine CCL19 | 1 | 2010 | 35 | 0.020 |
Why?
|
Touch | 1 | 2013 | 306 | 0.020 |
Why?
|
Testosterone | 1 | 2002 | 2419 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 693 | 0.020 |
Why?
|
Cause of Death | 1 | 2001 | 3582 | 0.020 |
Why?
|
Chemokine CCL21 | 1 | 2010 | 51 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2023 | 3589 | 0.020 |
Why?
|
Immunity, Cellular | 2 | 2014 | 1607 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2014 | 1892 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2018 | 2700 | 0.020 |
Why?
|
Cost of Illness | 1 | 2020 | 1860 | 0.020 |
Why?
|
Receptor, Endothelin A | 2 | 2000 | 58 | 0.020 |
Why?
|
Liver Diseases | 1 | 1999 | 1253 | 0.020 |
Why?
|
Endothelins | 2 | 2000 | 138 | 0.020 |
Why?
|
Receptors, Complement | 1 | 2010 | 264 | 0.020 |
Why?
|
Interleukin-15 | 1 | 2010 | 184 | 0.020 |
Why?
|
Catheter-Related Infections | 1 | 2012 | 252 | 0.020 |
Why?
|
Umbilical Veins | 1 | 2010 | 433 | 0.020 |
Why?
|
Neoplasms, Second Primary | 1 | 1997 | 1062 | 0.020 |
Why?
|
Tissue Preservation | 1 | 2010 | 182 | 0.020 |
Why?
|
Protective Agents | 1 | 2010 | 156 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2016 | 1837 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 1997 | 2190 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 35424 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2019 | 2795 | 0.020 |
Why?
|
Cytomegalovirus | 1 | 2012 | 733 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2011 | 940 | 0.020 |
Why?
|
Up-Regulation | 2 | 2010 | 4222 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2018 | 1978 | 0.020 |
Why?
|
Hypertension | 3 | 2004 | 8479 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1504 | 0.020 |
Why?
|
Canada | 1 | 2013 | 2065 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2014 | 2453 | 0.020 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2007 | 87 | 0.020 |
Why?
|
Viremia | 1 | 2010 | 736 | 0.020 |
Why?
|
Kidney Diseases, Cystic | 1 | 2008 | 186 | 0.020 |
Why?
|
Lower Extremity | 1 | 2014 | 1158 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2016 | 5077 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2011 | 6366 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 5868 | 0.020 |
Why?
|
Serum Albumin | 1 | 2009 | 675 | 0.020 |
Why?
|
Blood Urea Nitrogen | 1 | 2006 | 191 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2008 | 619 | 0.020 |
Why?
|
Observer Variation | 1 | 2012 | 2593 | 0.020 |
Why?
|
Communicable Diseases | 1 | 2014 | 880 | 0.020 |
Why?
|
Disease Progression | 2 | 2004 | 13285 | 0.020 |
Why?
|
Renal Veins | 1 | 2005 | 108 | 0.020 |
Why?
|
Glucose Tolerance Test | 2 | 1999 | 1150 | 0.020 |
Why?
|
Remission Induction | 1 | 2011 | 2386 | 0.020 |
Why?
|
Anti-Infective Agents | 1 | 2012 | 974 | 0.020 |
Why?
|
Safety | 1 | 2010 | 1186 | 0.020 |
Why?
|
Cell Death | 1 | 2010 | 1707 | 0.020 |
Why?
|
Neoplasms | 4 | 2014 | 21693 | 0.020 |
Why?
|
Adsorption | 1 | 2004 | 201 | 0.020 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2007 | 504 | 0.020 |
Why?
|
Probability | 1 | 2010 | 2506 | 0.010 |
Why?
|
Administration, Oral | 2 | 2004 | 3914 | 0.010 |
Why?
|
Peritoneal Lavage | 1 | 2004 | 35 | 0.010 |
Why?
|
Aorta, Thoracic | 1 | 2010 | 1084 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2887 | 0.010 |
Why?
|
Desoxycorticosterone | 1 | 2003 | 50 | 0.010 |
Why?
|
Neutrophils | 2 | 1994 | 3721 | 0.010 |
Why?
|
Gene Silencing | 1 | 2010 | 1539 | 0.010 |
Why?
|
Colony Count, Microbial | 1 | 2004 | 331 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2016 | 4464 | 0.010 |
Why?
|
Cecum | 1 | 2004 | 237 | 0.010 |
Why?
|
Immunoglobulin gamma-Chains | 1 | 2003 | 33 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2004 | 11525 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1999 | 4034 | 0.010 |
Why?
|
Ions | 1 | 2004 | 265 | 0.010 |
Why?
|
Severity of Illness Index | 2 | 2016 | 15535 | 0.010 |
Why?
|
Interleukin-12 Subunit p40 | 1 | 2003 | 55 | 0.010 |
Why?
|
Lactobacillus | 1 | 2004 | 189 | 0.010 |
Why?
|
Aorta | 1 | 2010 | 2062 | 0.010 |
Why?
|
Organoplatinum Compounds | 1 | 2004 | 408 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2010 | 1678 | 0.010 |
Why?
|
Diabetic Nephropathies | 1 | 2010 | 984 | 0.010 |
Why?
|
Liver Regeneration | 1 | 2004 | 210 | 0.010 |
Why?
|
Spleen | 2 | 2002 | 2362 | 0.010 |
Why?
|
Leucovorin | 1 | 2004 | 628 | 0.010 |
Why?
|
Adenoviridae Infections | 1 | 2003 | 96 | 0.010 |
Why?
|
Pelvic Neoplasms | 1 | 2004 | 254 | 0.010 |
Why?
|
Transfection | 1 | 2010 | 5895 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2012 | 8949 | 0.010 |
Why?
|
Permeability | 1 | 2004 | 738 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2018 | 3444 | 0.010 |
Why?
|
HLA-D Antigens | 1 | 2001 | 134 | 0.010 |
Why?
|
Organ Culture Techniques | 1 | 2004 | 813 | 0.010 |
Why?
|
Blood | 1 | 2004 | 598 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 5986 | 0.010 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2002 | 241 | 0.010 |
Why?
|
Viral Load | 1 | 2010 | 3300 | 0.010 |
Why?
|
Pneumonia | 1 | 2012 | 2133 | 0.010 |
Why?
|
Receptor, Endothelin B | 1 | 2000 | 41 | 0.010 |
Why?
|
Gastric Mucosa | 1 | 2004 | 599 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2006 | 1970 | 0.010 |
Why?
|
Hypocalcemia | 1 | 2001 | 191 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 25041 | 0.010 |
Why?
|
Lamivudine | 1 | 2001 | 342 | 0.010 |
Why?
|
Intubation, Intratracheal | 1 | 2008 | 1364 | 0.010 |
Why?
|
Phenylpropionates | 1 | 1999 | 30 | 0.010 |
Why?
|
Myocardium | 1 | 2013 | 4772 | 0.010 |
Why?
|
Receptors, Endothelin | 1 | 1999 | 58 | 0.010 |
Why?
|
Prolactin | 1 | 2002 | 669 | 0.010 |
Why?
|
Genes, MHC Class II | 1 | 2000 | 457 | 0.010 |
Why?
|
Heart | 1 | 2013 | 4464 | 0.010 |
Why?
|
Fluorouracil | 1 | 2004 | 1619 | 0.010 |
Why?
|
GTPase-Activating Proteins | 1 | 2002 | 498 | 0.010 |
Why?
|
Disease-Free Survival | 2 | 2001 | 6896 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3921 | 0.010 |
Why?
|
CD4-CD8 Ratio | 1 | 1998 | 112 | 0.010 |
Why?
|
Mitosis | 1 | 2004 | 1208 | 0.010 |
Why?
|
Adenoviridae | 1 | 2003 | 1101 | 0.010 |
Why?
|
Algorithms | 2 | 2013 | 13882 | 0.010 |
Why?
|
Lipopolysaccharides | 2 | 1996 | 2216 | 0.010 |
Why?
|
Vocal Cord Paralysis | 1 | 2001 | 267 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2013 | 4925 | 0.010 |
Why?
|
Lymphoma | 2 | 1997 | 1877 | 0.010 |
Why?
|
Actuarial Analysis | 1 | 1998 | 378 | 0.010 |
Why?
|
Endothelin-1 | 1 | 1999 | 314 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7281 | 0.010 |
Why?
|
Nervous System Diseases | 2 | 1998 | 1622 | 0.010 |
Why?
|
Hepatocytes | 1 | 2004 | 1211 | 0.010 |
Why?
|
RNA | 1 | 2007 | 2749 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 1998 | 645 | 0.010 |
Why?
|
Brain | 1 | 2023 | 26386 | 0.010 |
Why?
|
Molecular Weight | 1 | 1998 | 2255 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2004 | 9240 | 0.010 |
Why?
|
Computer Simulation | 2 | 1999 | 6194 | 0.010 |
Why?
|
Rectal Neoplasms | 1 | 2004 | 1205 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2011 | 13988 | 0.010 |
Why?
|
Cross Infection | 1 | 2004 | 1417 | 0.010 |
Why?
|
Monocytes | 2 | 1994 | 2596 | 0.010 |
Why?
|
Apoptosis | 1 | 2010 | 9726 | 0.010 |
Why?
|
DNA Primers | 1 | 1998 | 2891 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2012 | 19905 | 0.010 |
Why?
|
Hydrocortisone | 1 | 2002 | 1826 | 0.010 |
Why?
|
Menopause | 1 | 2002 | 1626 | 0.010 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2002 | 2015 | 0.010 |
Why?
|
Uterine Cervical Dysplasia | 1 | 1997 | 387 | 0.010 |
Why?
|
Bone Marrow | 1 | 2004 | 2948 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2004 | 4851 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2003 | 3424 | 0.010 |
Why?
|
Genes, Immunoglobulin | 1 | 1994 | 291 | 0.010 |
Why?
|
Postmenopause | 1 | 2002 | 2460 | 0.010 |
Why?
|
Hyperlipidemias | 1 | 1997 | 789 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2001 | 6171 | 0.010 |
Why?
|
Bone Density | 1 | 2005 | 3468 | 0.010 |
Why?
|
Morbidity | 1 | 1997 | 1768 | 0.010 |
Why?
|
Extracellular Matrix Proteins | 1 | 1996 | 850 | 0.010 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 1994 | 357 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2009 | 5749 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 1997 | 2560 | 0.010 |
Why?
|
Fibrin | 1 | 1993 | 506 | 0.010 |
Why?
|
Triglycerides | 1 | 1998 | 2453 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14723 | 0.010 |
Why?
|
Interleukin-1 | 1 | 1994 | 1263 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 1993 | 927 | 0.010 |
Why?
|
Cholesterol | 1 | 1998 | 2919 | 0.010 |
Why?
|
Integrins | 1 | 1993 | 846 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 1993 | 1537 | 0.000 |
Why?
|
Base Sequence | 1 | 1998 | 12797 | 0.000 |
Why?
|
Adenocarcinoma | 1 | 2004 | 6364 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1998 | 13814 | 0.000 |
Why?
|
Hepatitis C | 1 | 1996 | 1591 | 0.000 |
Why?
|
Child, Preschool | 2 | 1999 | 41005 | 0.000 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2010 | 11725 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1998 | 18111 | 0.000 |
Why?
|
Leukocytes | 1 | 1993 | 2045 | 0.000 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1997 | 2020 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1999 | 12961 | 0.000 |
Why?
|
Models, Biological | 1 | 1998 | 9584 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2004 | 13695 | 0.000 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 1997 | 9957 | 0.000 |
Why?
|
Skin Neoplasms | 1 | 1997 | 5692 | 0.000 |
Why?
|